BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins

被引:161
作者
Zhang, H [1 ]
Xu, QL [1 ]
Krajewski, S [1 ]
Krajewska, M [1 ]
Xie, ZH [1 ]
Fuess, S [1 ]
Kitada, S [1 ]
Pawlowski, K [1 ]
Godzik, A [1 ]
Reed, JC [1 ]
机构
[1] Burnham Inst, Program Apoptosis & Cell Death Regulat, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.97.6.2597
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Two major pathways for induction of apoptosis have been identified-intrinsic and extrinsic. The extrinsic pathway is represented by tumor necrosis factor family receptors, which utilize protein interaction modules known as death domains and death effector domains (DEDs) to assemble receptor signaling complexes that recruit and activate certain caspase-family cell death proteases, namely procaspases-8 and -10. The intrinsic pathway for apoptosis involves the participation of mitochondria, which release caspase-activating proteins. Bcl-2 family proteins govern this mitochondria-dependent apoptosis pathway, with proteins such as Bar functioning as inducers and proteins such as Bcl-2 and Bcl-X-L serving as suppressors of cell death. An apoptosis regulator, BAR, was identified by using a yeast-based screen for inhibitors of Bar-induced cell death. The BAR protein contains a SAM domain, which is required for its interactions with Bcl-2 and Bcl-X-L and for suppression of Bar-induced cell death in both mammalian cells and yeast. In addition, BAR contains a DED-like domain responsible for its interaction with DED-containing procaspases and suppression of Fas-induced apoptosis, Furthermore, BAR can bridge procaspase-8 and Bcl-2 into a protein complex. The BAR protein is anchored in intracellular membranes where Bcl-2 resides. BAR therefore may represent a scaffold protein capable of bridging two major apoptosis pathways.
引用
收藏
页码:2597 / 2602
页数:6
相关论文
共 46 条
[21]   Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade [J].
Li, P ;
Nijhawan, D ;
Budihardjo, I ;
Srinivasula, SM ;
Ahmad, M ;
Alnemri, ES ;
Wang, XD .
CELL, 1997, 91 (04) :479-489
[22]   Release of cytochrome c and decrease of cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-x(L) [J].
Manon, S ;
Chaudhuri, B ;
Guerin, M .
FEBS LETTERS, 1997, 415 (01) :29-32
[23]   Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex [J].
Medema, JP ;
Scaffidi, C ;
Krammer, PH ;
Peter, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3388-3393
[24]   FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex [J].
Muzio, M ;
Chinnaiyan, AM ;
Kischkel, FC ;
ORourke, K ;
Shevchenko, A ;
Ni, J ;
Scaffidi, C ;
Bretz, JD ;
Zhang, M ;
Gentz, R ;
Mann, M ;
Krammer, PH ;
Peter, ME ;
Dixit, VM .
CELL, 1996, 85 (06) :817-827
[25]   Apoptosis by death factor [J].
Nagata, S .
CELL, 1997, 88 (03) :355-365
[26]   Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria [J].
Narita, M ;
Shimizu, S ;
Ito, T ;
Chittenden, T ;
Lutz, RJ ;
Matsuda, H ;
Tsujimoto, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14681-14686
[27]   p28 Bap31, a Bcl-2/Bcl-X-L- and procaspase-8-associated protein in the endoplasmic reticulum [J].
Ng, FWH ;
Nguyen, M ;
Kwan, T ;
Branton, PE ;
Nicholson, DW ;
Cromlish, JA ;
Shore, GC .
JOURNAL OF CELL BIOLOGY, 1997, 139 (02) :327-338
[28]   Does the Caenorhabditis elegans protein CED-4 contain a region of homology to the mammalian death effector domain? [J].
Peter, ME ;
Medema, JP ;
Krammer, PH .
CELL DEATH AND DIFFERENTIATION, 1997, 4 (07) :523-525
[29]   A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection [J].
Rodriguez, I ;
Matsuura, K ;
Khatib, K ;
Reed, JC ;
Nagata, S ;
Vassalli, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :1031-1036
[30]  
Rost B, 1996, METHOD ENZYMOL, V266, P525